Honokiol is a small molecular weight ligand originally isolated from the Chinese medicinal herb Magnolia officinalis, a plant used in traditional Chinese and Japanese medicine [9] . In a previous study, the effects of honokiol were shown to have anti-angiogenic, anti-invasive and anti-proliferative activities in a variety of cancers [1, 3, 4, 11, 13, 17, 24, 29, 30] . We showed previously that direct production of nitric oxide (NO) by treatment of NO donor, sodium nitroprusside (SNP), led to apoptosis in rabbit articular chondrocytes [15, 16] . This study confirmed that NO-induced apoptosis was suppressed by honokiol treatment in a dose-dependent manner as determined by cell phenotype, MTT assay, Western blot analysis and FACS analysis in articular chondrocytes. Treatment of honokiol inhibited SNP-induced expression of p53 as well as DNA fragmentation in articular chondrocytes, but increased expressionof pro-caspase-3. Inhibition of SNP-induced apoptosis by honokiol treatment was rescued by LY294002, the specific inhibitors of phosphoinositide 3-kinase (PI-3K) in articular chondrocytes.
Introduction
Honokiol [C18H18O2, molecular weight=266.33] (Fig. 1) is TNFα-related a small molecular weight ligand,originally isolated from the Chinese medicinal herb 'Magnolia officinalis', a plant used in traditional Chinese and Japanese medicine of many diseases [9] . Honokiol, one of the major phenolic constituents of magnolia bark, have several pharmacological effects such as anti-oxidant [20] , anti-thrombosis [26] , anti-bacterial, xanthine oxidase inhibition, anti-tumor, anti-platelet aggregation, anti-inflammatory effects [19] , anti-arrhythmic [18] and anxiolytic effect [28] . Previous reports have demonstrated that honokiol exhibited remarkable inhibitory effects on mouse skin tumor promotion in an in vivo two-stage carcinogenesis, and inhibited the growth of human leukemic HL-60 cells [8] . Moreover, honokiol has induced apoptosis which characterized by DNA fragmentation and apoptotic bodies in human lymphoid leukemia Molt 4B cell [11] .
Chondrocytes in cartilage are differentiated from mesenchymal cells during embryonic development. Differentiated chondrocytes, which are the only cell type found in normal mature cartilage, synthesize sufficient amounts of cartilage-specific extracellular matrix (ECM) to maintain matrix integrity. This homeostasis is demolished in degenerative diseases, such as osteoarthritis (OA) and rheumatoid arthritis (RA) [7, 23] . Arthritis is characterized by structural and biochemical changes in chondrocytes and cartilage, including degradation of cartilage matrix, insufficient synthesis of ECM caused loss of chondrocyte phenotype.
It is now generally accepted that proinflammatory cytokines, such as interleukin-1 beta (IL-1β) and tumor necrosis factor-alpha (TNFα), play a predominant role in structural and biochemical alterations in chondrocyte and cartilage [7] .
One of the leading mechanisms by which cytokines elicit their effects on cartilage involves the stimulation of nitric oxide (NO) production via inducible NO synthase [2, 21] .
Although NO-induced cartilage destruction is caused by various factors, increased apoptotic cell death [5, 10, 31] and loss of differentiated phenotype of articular chondrocytes [6, 25] appear to be important contributors. Our previously results showed that direct production of NO by treatment of NO donor, sodium nitroprusside (SNP), in primary cultured articular chondrocytes, led to apoptosis, dedifferentiation, and cyclooxygenase (COX)-2 expression via a complex protein kinase signaling cascade involving mitogen-activated protein (MAP) kinase and protein kinase C (PKC) [14] [15] [16] . However, the regulatory mechanism of NO-induced apoptosis has not been clearly elucidated yet. This study addressed the effects of honokiol on the regulation of NO-induced apoptosis by SNP, and suggests that inhibition of No-induced apoptosis by honokiol is required for PI-3 Kinase-dependent pathway.
Materials and Methods
Cell culture Rabbit articular chondrocytes were isolated from cartilage slices of 2-week-old New Zealand white rabbits by enzymatic digestion as described previously [33] . Cartilage slices were dissociated enzymatically for 6 hr in 0.2% collagenase type II (381 U/mg solid, Sigma, Louis, MO) in Dulbecco's modified Eagle's medium (DMEM) (Gibco-BRL, Gaithersburg, MD). Individual cells were suspended in DMEM supplemented with 10% (v/v) fetal bovine-calf serum, 50 g/ml streptomycin, and 50 units/ml penicillin, after which and they were then plated on culture dishes at a density of 5×10 4 cells/cm 2 . The medium was changed every 2 days after seeding, and cells reached confluence in approximately 5 days. The 3.5 day cell cultures were treated with honokiol. Honokiol was purchased from Wako (Wako, Osaka) and a stock solution (MW: 266.33, 100 mM) in DMSO prepared and stored at 4℃ The following pharmacological agents were added 1 hr prior to honokiol, LY294002 to inhibit PI-3 kinase. LY294002 war obtained from BioMol (BioMol, PA).
Western blot analysis
Whole cell lysates were prepared by extracting proteins using a buffer containing 50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% Nonidet P-40, and 0.1% sodium dodecylsulfate (SDS), supplemented with protease inhibitors [10 g/ml leupeptin, 10 g/ml pepstatin A, 10 g/ml aprotinin and 1 mM of 4-(2-aminoethyl) benzenesulfonyl fluoride] and phosphatase inhibitors (1 mM NaF and 1 mM Na3VO4). The lysa-teswere size-fractionated by SDS-polyacrylamide gel electrophoresis and transferred to a nitrocellulose membrane. The nitrocellulose sheet was then blocked with 3% non-fat dry milk in Tris-buffered saline. Expression of caspase-3 and pAkt were detected using antibody purchased from Cell Signaling Technology (Danvers, MA), and p53 and Actinwere detected using antibodies purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Blots were developed using a peroxidase-conjugated secondary antibody and visualized with an ECL system.
Cell Proliferation assay
We used the MTT assay to quantify the proliferation of cells treated with honokiol and with SNP. Cells were seeded in 96-well plates at a density of 2×10 4 cells per well for 24 hr. Cells were treated with honokiol and were treated with SNP. 10 μl MTT reagent 1 was added to the cells per well. The plate was incubated for 4 hr at 37℃until purple formazan crystal developed. And, 100 μl MTT reagent 2 was added to the cells per well. After overnight in incubator, the absorbance at 600 nm was read and four wells were examined with a spectrophotometer for each treatment.
Cell cycle distribution by FACS analysis
Cell cycle distribution was assessed by staining DNA content with propidium iodide as previously described method [12] with some modifications. Briefly, chondrocytes were plated at a density of 2×10 5 cells per 35-mm culture dish and incubated for 24 hr. Fresh complete media containing serially diluted honokiol were replaced to culture dishes and further incubated for 24 hr. After incubation, both adherent and floating cells were harvested and fixed with 80% ethanol in PBS overnight. Fixed cells were incubated with RNase A (50 μg/ ml) for 25 min prior to staining nucleic acid with propidium iodide (50 μg/ml) for 5 min. The DNA content of 2×10 4 cells in each group was analyzed by flow cytometer (Partec GmbH, Münster, Germany) and the results were demonstrated as histograms of DNA content. Quantification of the distinct cell cycle phases was calculated using the FloMax program.
DNA fragmentation
Cellular DNA was extracted after treatment of indicated honokiol with SNP for 24 hr. Briefly, whole cells were washed with PBS and resuspended with lysis buffer containing 50 mM Tris-HCl (pH 7.5), 20 mM EDTA, and 1% NP-40. After centrifugation at 3,000 rpm for 5 min, 10 μl of 10% Western blot analysis quantified by densitometric analysis respectively ( Fig. 2C and 2D ).
Apoptotic cell death was blocked in chondrocytes with SNP (1 mM) and honokiol (10 μM) for 24 hr (Fig. 3A) . This result was demonstrated as histograms of DNA content. The distribution of cells in each phase of cell cycle was calculated using FloMax program (Fig. 3B, upper and lower panel) . As shown in Fig. 3B , about 34% of the cells were increased at sub G1 phase and 46% of the cells decreased at G1 phase after treatment with SNP alone compared with those in controls. When SNP was combined with honokiol, the cells of sub G1 phase were dramatically decreased and the cells of G1 phase were increased compared with those in SNP treatment cells. The results indicate that induction of apoptosis was occured by transition of G1 cells to sub G1 cells.
To elucidate the mechanism of honokiol-regulated apoptosis, caspase-3, an executioner of cell death, and p53, a signaling molecule upstream of caspase-3, were examined, and phosphorylation of AKT, known as a survival signaling molecule downstream of PI-3K was also investigated in rabbit articular chondrocytes (Fig. 4A ). SNP-induced p53 was blocked by treatment of honokiol, effectively. As anticipated, pro-caspase-3 and pAKT expression was rescued by treatment of honokiol. It was determined that the protein levels of p53, pro-casepase-3 and pAKT were subsequently quantified by densitometric analysis (Fig. 4B) . Consistent with the result of Fig. 4A , honokiol significantly blocked NO-induced apoptotic cell death, as determined by DNA fragmentation (Fig. 4C) . These results indicate that honokiol effectively recovered NO caused apoptotic cell death in rabbit articular chondrocytes.
Inhibitory effect of honokiol on the NO-induced apoptosis is required for PI-3K/AKT-dependent pathway
To further investigate anti-apoptotic effects regulated by honokiol, LY294002, a well known signaling molecule up-stream of PI-3K/AKT was treated in chondrocytes to block activation of PI-3K/AKT. In consequence, anti-apoptotic effects of honokiol were significantly inhibited in chondrocytes (Fig. 5A ), and these inhibition by LY294002 increased NO-induced apoptosis (Fig. 5B ). LY294002 increases suppression of the p53 which honokiol leads. However increase of pro-caspase-3 is inhibited by LY294002 in articular chondrocytes (Fig. 5C ). These protein levels were quantified by densitometric analysis (Fig. 5D ). These findings collectively suggest that PI3K/AKT is required for inhibition of NO-induced apoptosis by honokiol in articular chondrocytes.
Discussion
Recently, alternative mechanisms of action have been proposed to account for the anti-tumor effect of honokiol and many studies have been initiated to explore the anti-tumor efficacy of honokiol. Also, the growth inhibition of tumor by honokiol is highly related to cell cycle arrest at the G0/G1 phase and induction of apoptosis [27] .
NO mediates the regulation and survivalof chondrocyte phenotype by inducing dedifferentiation and apoptosis. Our previous results showed that apoptosis of chondrocyte caused by direct production of NO with the SNP is regulated by opposite functions of two mitogen-activated protein kinase subtypes, extracellular signal-regulated kinase-1/-2 (ERK-1/-2) and p38 kinase, in association with the elevation of p53 protein level, caspase-3 activation, and differentiation status [14] [15] [16] . SNP treatment stimulated activation of both ERK-1/-2 and p38 kinase. The activated ERK-1/-2 plays a role as an inhibitory signal for NO-induced apoptosis, whereas p38 kinase functions as a signal for the maintenance of the differentiated status and an inducing signal for apoptosis of chondrocytes. And, we also reported that NO production in articular chondrocytes inhibits cell survival signaling, including apoptosis [22] . IGF-1 inhibits NO-induced apoptosis and dedifferentiation by modulating actin cytoskeletal architecture. Actin cytoskeleton regulates these func- 
